1. Home
  2. EOSE vs OGN Comparison

EOSE vs OGN Comparison

Compare EOSE & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eos Energy Enterprises Inc.

EOSE

Eos Energy Enterprises Inc.

HOLD

Current Price

$3.48

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.52

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EOSE
OGN
Founded
2008
1923
Country
United States
United States
Employees
787
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EOSE
OGN
Price
$3.48
$13.52
Analyst Decision
Hold
Hold
Analyst Count
7
5
Target Price
$9.42
$11.40
AVG Volume (30 Days)
22.5M
2.4M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$172.02
$0.45
Revenue Next Year
$97.32
$1.67
P/E Ratio
N/A
$24.65
Revenue Growth
N/A
N/A
52 Week Low
$3.65
$5.69
52 Week High
$19.86
$13.60

Technical Indicators

Market Signals
Indicator
EOSE
OGN
Relative Strength Index (RSI) 26.98 62.05
Support Level N/A $13.46
Resistance Level $8.15 $13.60
Average True Range (ATR) 0.42 0.04
MACD -0.02 -0.02
Stochastic Oscillator 0.58 62.50

Price Performance

Historical Comparison
EOSE
OGN

About EOSE Eos Energy Enterprises Inc.

Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: